Literature DB >> 228052

Induction of thymidine kinase and DNase in varicella-zoster virus-infected cells and kinetic properties of the virus-induced thymidine kinase.

Y C Cheng, T Y Tsou, T Hackstadt, L P Mallavia.   

Abstract

Thymidine kinase (TK), DNA polymerase, and DNase activities were induced in human foreskin fibroblasts after varicella-zoster virus infection. The induced TK and DNase activities have electrophoretic mobilities different from the corresponding host enzymes. Varicella-zoster virus-induced TK was purified and separated from the host enzyme by affinity column chromatography. This enzyme has been shown to have a broader substrate specificity with respect to either the phosphate donor or acceptor as compared with human cytoplasmic and mitochondrial TKs. The best phosphate donor is ATP, with a Km of 16 microM. The Km values of thymidine, deoxycytidine, and 5-propyl deoxyuridine were estimated to be 0.4, 180, and 0.8 microM, respectively. The Ki values for several analogs of thymidine such as 5-iododeoxyuridine, arabinofuranosylthymine, 5-ethyl deoxyuridine, and 5-cyanodeoxyuridine were also examined. TTP acted as a noncompetitive inhibitor with respect to thymidine with a Ki of 5 microM. The kinetic behavior of varicella-zoster virus-induced TK is different from human cytoplasmic, human mitochondrial, and herpes simplex virus type 1- and 2-induced TKs.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 228052      PMCID: PMC353432     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  INHIBITION BY METABOLIC ANALOGUES OF PLAQUE FORMATION BY HERPES ZOSTER AND HERPES SIMPLEX VIRUSES.

Authors:  F RAPP
Journal:  J Immunol       Date:  1964-10       Impact factor: 5.422

2.  A rational approach to the development of antiviral chemotherapy: alternative substrates of herpes simplex virus Type 1 (HSV-1) and Type 2 (HSV-2) thymidine kinase (TK).

Authors:  Y C Cheng
Journal:  Ann N Y Acad Sci       Date:  1977-03-04       Impact factor: 5.691

3.  Purification and characterization of varicella-zoster virus-induced DNA polymerase.

Authors:  E C Mar; Y S Huang; E S Huang
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

4.  The deoxyribonuclease induced after infection of KB cells by herpes simplex virus type 1 or type 2. I. Purification and characterization of the enzyme.

Authors:  P J Hoffmann; Y C Cheng
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

5.  9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group.

Authors:  H J Schaeffer; L Beauchamp; P de Miranda; G B Elion; D J Bauer; P Collins
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

6.  Behavior of various ribo- and deoxyribonucleosides, nucleoside monophosphate kinases, and nucleoside diphosphokinase on Blue Sepharose affinity columns.

Authors:  Y C Cheng; B Domin
Journal:  Anal Biochem       Date:  1978-04       Impact factor: 3.365

7.  Epstein-Barr virus-associated thymidine kinase.

Authors:  S T Chen; J E Estes; E S Huang; J S Pagano
Journal:  J Virol       Date:  1978-04       Impact factor: 5.103

8.  Stimulation of cellular thymidine kinases by human cytomegalovirus.

Authors:  J E Estes; E S Huang
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

9.  Deoxypyrimidine nucleoside metabolism in varicella-zoster virus-infected cells.

Authors:  T Hackstadt; L P Mallavia
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

10.  Induction of deoxypyrimidine kinase activity in human embryonic lung cells infected with varicella-zoster virus.

Authors:  T Ogino; T Otsuka; M Takahashi
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

View more
  17 in total

1.  Demonstration of viral thymidine kinase inhibitor and its effect on deoxynucleotide metabolism in cells infected with herpes simplex virus.

Authors:  L M Nutter; S P Grill; G E Dutschman; R A Sharma; M Bobek; Y C Cheng
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

2.  Characterization of the Epstein-Barr virus-encoded thymidine kinase expressed in heterologous eucaryotic and procaryotic systems.

Authors:  E Littler; J R Arrand
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

3.  Characterization of an Epstein-Barr virus-induced thymidine kinase.

Authors:  M de Turenne-Tessier; T Ooka; G de The; J Daillie
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

4.  Acyclic guanosine analogs as substrates for varicella-zoster virus thymidine kinase.

Authors:  A R Karlström; C F Källander; G Abele; A Larsson
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

5.  In vitro susceptibility of varicella-zoster virus to acyclovir.

Authors:  K K Biron; G B Elion
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

6.  Rapid typing of herpes simplex virus based on immunological specificity of viral thymidine kinase and typing according to sensitivity to iododeoxyuridine.

Authors:  J S Gronowitz; C F Källander; S Jeansson; J Wallin
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

7.  Differences in the kinetic properties of thymidine kinase isoenzymes in unstimulated and phytohemagglutinin-stimulated human lymphocytes.

Authors:  B Munch-Petersen
Journal:  Mol Cell Biochem       Date:  1984-09       Impact factor: 3.396

8.  Genome structure and virion polypeptides of the primate herpesviruses Herpesvirus aotus types 1 and 3: comparison with human cytomegalovirus.

Authors:  A Ebeling; G Keil; B Nowak; B Fleckenstein; N Berthelot; P Sheldrick
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

9.  Biochemical characterization of equine herpesvirus type 3-induced deoxythymidine kinase purified from lytically infected horse embryo dermal fibroblasts.

Authors:  J J McGowan; G P Allen; J M Barnett; G A Gentry
Journal:  J Virol       Date:  1980-05       Impact factor: 5.103

10.  In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.

Authors:  E De Clercq; J Descamps; M Ogata; S Shigeta
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.